Gunot, Daizelle M.
HRN: 18-49-54 Sex: FemalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/14/2023
CEFTAZIDIME 1GM (VIAL)
05/14/2023
05/20/2023
IV
417mg
Q8
Pcap Severe
Waiting Final Action